Kimpharm Limited was set up on Monday the 28th of July 2025. Their current partial address is Dublin 6w, and the company status is Normal. The company's current directors have been the director of 4 other Irish companies between them.
| Company Name: | Kimpharm Limited |
| Company Status: | NORMAL |
| Company Address: | Thom's Pharmacy, 151 Lower Kimmage Road, Kimmage, Dublin 6w, Ireland |
| Key Executive: | Ms O'Dwyer |
| Company Size: | Log-In To View |
Ms O'Dwyer is a Company Director of Kimpharm Limited since 2025 and a listed Director of 4 other companies.
Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.
Similar Companies - Create a marketing list of similar companies
The latest documents filed with the Companies Registration Office for Kimpharm Limited (which can include the Account Details) are listed below.
View CRO company documents and company reports any Irish company or business with ease.
Satisfy due diligence requirements on Kimpharm Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Kimpharm Limited and Anti-Money Laundering checks (AML checks) on Kimpharm Limited
| Company Type: | LTD - Private Company Limited By Shares |
Log-in now to run Due Diligence checks and Compliance checks on Kimpharm Limited or click Join-up to get started.
Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.
More people choose Vision-net over any other search service... ask us why?
28/07/2025
Looking to achieve better and cleaner data? CRIFVision-net helps you get the most out of your data.
14/07/2025
For the first six months of 2025, a 9% year-on-year increase of company start-ups was recorded.
07/07/2025
According to our latest figures a 9% year-on-year increase in the number of company start-ups
30/06/2025
Over the past six months, Ireland has seen a modest decline in new directorship appointments.
